Terpos, E., Gavriatopoulou, M., Ntanasis-Stathopoulos, I., Malandrakis, P., Fotiou, D., Kanellias, N., Migkou, M., Theodorakakou, F., Spiliopoulou, V., Solia, E., Eleutherakis-Papaiakovou, E., Psarros, G., Kastritis, E., Dimopoulos, M. A. (2026). Belantamab mafodotin, lenalidomide, and dexamethasone for intermediate-fit and frail patients with newly diagnosed myeloma. Blood. https://doi.org/10.1182/blood.2025031629